Dr. rer. nat. Simon Völkl

Department of Medicine 5 – Haematology and Oncology

Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies (2024) Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kleyer A, Gary R, et al. Journal article, Letter BCL10 Deficiency Presenting as Severe Combined Immunodeficiency Escaping Newborn Screening (2024) Salou S, Völkl S, Keller B, Ehl S, Naumann-Bartsch N Journal article CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up. (2024) Müller F, Taubmann J, Bucci L, Wilhelm A, Bergmann C, Völkl S, Aigner M, et al. Journal article Detection of signature double-negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function (2024) Eisenhauer N, Miano M, Naumann-Bartsch N, Leyh J, Dell'Orso G, Aigner M, Fecker G, et al. Journal article CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus. (2024) Taubmann J, Müller F, Mutlu MY, Völkl S, Aigner M, Bozec A, Mackensen A, et al. Journal article, Review article Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation (2024) Richter S, Böttcher M, Stoll A, Zeremski V, Völkl S, Mackensen A, Ekici AB, et al. Journal article Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy (2023) Nunez D, Patel D, Volkov J, Wong S, Vorndran Z, Müller F, Aigner M, et al. Journal article Identification and characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains (2023) Reimann H, Moosmann C, Schober K, Lang V, Verhagen J, Zeun J, Mackensen A, et al. Journal article Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023) Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al. Journal article, Letter Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT (2023) Karl F, Liang C, Böttcher-Loschinski R, Stoll A, Flamann C, Richter S, Lischer C, et al. Journal article